COVID-19 Records

Gates Package — page 868

of 1375 pages

← p.867 p.869 → · this page in the original PDF · package

treatment and cure I > 8 AM AID) [E] ny (NIH/NIAID) I I > will likely discuss is the Are there any new »f this partnership. iteration of this strategy has been completed, now on to version 2.0. Last, the plans for an bNAb treatment and cure trial in Africa with BMGF is moving forward. Waiting for BMGF to finish production of the bNAbs. This continues to be parallel and complementary activities with BMGF. Best regards, Carl From: Collins, Francis (NIH/NHGRI) [E] @nih.gov> Sent: Tuesday, September 27, 2022 6:48 AM To: Gibbons, Gary (NIH/NHLBI) [E] @nih.gov>; Panepinto, Julie (NIH/NHLBI) [E] @nih.gov>; Dieffenbach, Carl (NIH/NIAID) [E] @niaid.nih.gov>; Fauci, Anthony (NIH/NIAID) [E] @niaid.nih.gov> Cc: Tabak, Lawrence (NIH/OD) [E] @nih.gov>; Schwetz, Tara (NIH/OD) [E] @nih.gov> Subject: Seeing Bill Gates tomorrow Hi all, Bill Gates is at the White House tomorrow and asked to see me at 9 AM. Among the topics we will likely discuss is the HIV-SCD joint NIH-BMGF effort to develop cures that will be applicable in low income settings. Are there any new developments since the Sunnylands meeting back in May? Bill will likely ask about the future of this partnership. Thanks, Francis

This is our OCR of the page, with running headers and footers removed. The Committee's PDF is authoritative; quote from it. Machine-readable, including the uncleaned text: /api/page/gates/868

Records on this page

RecordDateTypePages
gates:email:00754 email 867–868
Seeing Bill Gates tomorrow 2022-09-27 email 868–869